Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis

American Journal of Rhinology and Allergy

Volumn 24, Issue 1, 2010, Pages

  Wandalsen, Gustavo F ^a   Mendes, Aline I ^a   Solé, Dirceu ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acoustic rhinometry; Allergic rhinitis; Nasal congestion; Nasal hyperreactivity; Nasal provocation test; Nasal steroid; Symptoms scores

Indexed keywords

HISTAMINE; MOMETASONE FUROATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HISTAMINE RELEASE; HUMAN; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; NOSE DISEASE; NOSE HYPERREACTIVITY; NOSE PROVOCATION TEST; PERENNIAL RHINITIS; PRESCHOOL CHILD; RHINOMETRY; SCHOOL CHILD; SYMPTOM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANTI-ALLERGIC AGENTS; CHILD; DISEASE PROGRESSION; FEMALE; HISTAMINE; HUMANS; MALE; NASAL OBSTRUCTION; NASAL PROVOCATION TESTS; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; RHINOMETRY, ACOUSTIC;

EID: 75749122639     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3427     Document Type: Article

References (35)

1. Meltzer E, Orgel H, Bronsky E, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 86:221-230, 1990.
2. Davies R, and Nelson H. Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther 19:27-38, 1997.
3. Meltzer E, Jalowayski A, Orgel A, and Harris A. Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol 102:39-49, 1998.
4. Bousquet J, Khaltaev N, Cruz A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 63(suppl 86):8-160, 2008.
5. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55:16-134, 2000.
6. Weiner J, Abramson M, and Puy R. Intranasal corticosteroids versus oral H1 receptor in allergic rhinitis: Systematic review of randomized controlled trials. BMJ 317:1624-1629, 1998.
7. Brannan M, Herron J, and Affrime M. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther 19:1330-1339, 1997.
8. Mandl M, Nolop K, and Lutsky B. Comparison of once daily mometasone furoate and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 79:370-378, 1997.
9. van Spronsen E, Ingels K, Jansen A, et al. Evidence-based recommendations regarding the differential diagnosis and assessment of nasal congestion: using the new GRADE system. Allergy 63:820-833, 2008.
10. Oppenheimer J, and Nelson H. Skin testing. Ann Allergy Asthma Immunol 96(suppl 1):S6-S12, 2006.
11. Clement P, and Gordts F. Consensus report on acoustic rhinometry and rhinomanometry. Rhinology 43:169-179, 2005.
12. Unno T, Naitoh Y, Sakamoto N, and Horigana H. Nasal resistance measured by anterior rhinomanometry. Rhinology 24:49-55, 1986.
13. Nathan R. The pathophysiology, clinical impact, and management of nasal congestion in allergic rhinitis. Clin Ther 30:573-586, 2008.
14. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 62(suppl 85):9-16, 2007.
15. Hilberg O, Jackson A, Swift D, and Pedersen O. Acoustic rhinometry: Evaluation of nasal cavity geometry by acoustic reflection. J Appl Physiol 66:295-303, 1989.
16. Terheyden H, Maune S, Mertens J, and Hilberg O. Acoustic rhinometry: Validation by three-dimensionally reconstructed computer tomographic scans. J Appl Physiol 89:1013-1021, 2000.
17. Hilberg O. Objective measurement of nasal airway dimensions using acoustic rhinometry: Methodological and clinical aspects. Allergy 57(suppl 70):S5-S39, 2002.
18. Chan K, Huang Z, and Wang D. Acoustic rhinometry assessment of nasal obstrution after treatment with fluticasone propionate in patients with perennial rhinitis. Aurius Nasus Laryngx 30:379-383, 2003.
19. Nielsen L, Bjerke T, Christensen M, et al. Assessment of the allergic reaction in seasonal rhinitis: Acoustic rhinometry is a sensitive and objective method. Clin Exp Allergy 26:1268-1275, 1996.
20. Tahamiler R, Yener M, and Canakcioglu S. Efficacy of Odiosoft-Rhino in assessment of nasal obstruction: A comparative study with acoustic rhinometry after treatment with budesonide nasal spray in patients with perennial allergic rhinitis. Am J Rhinol 21:711-715, 2007.
21. Wilson A, Sims E, Orr L, et al. An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge. Br J Clin Pharmacol 55: 354-359, 2003.
22. Wilson A, Sims E, Orr L, et al. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 87:344-349, 2001.
23. Qian W, Chen W, Chen J, and Hiaght J. Acoustic rhinometry in preschool children. Otolaryngol Head Neck Surg 137:39-42, 2007.
24. Straszek S, Schlünssen V, Sigsgaard T, and Pedersen O. Reference values for acoustic rhinometry in decongested school children and adults: The most sensitive measurement for change in nasal patency. Rhinology 45:36-39, 2007.
25. Nathan R, Eccles R, Howarth P, et al. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 115(suppl 3):S442-S459, 2005.
26. Wijk R. Nasal hyperreactivity: Its pathogenesis and clinical significance. Clin Exp Allergy 21:661-667, 1991.
27. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 105:S599-S604, 2000.
28. Giannico R, Oliveira C, Solé D, and Naspitz C. Non-specific nasal provocation in children with allergic rhinitis. J Invest Allergol Clin Immunol 6:110-116, 1996.
29. Wijk R, and Dieges P. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy 17:563-570, 1987.
30. Mullins R, Olson L, and Sutherland D. Nasal histamine challenges in symptomatic allergic rhinitis. J Allergy Clin Immunol 83:955-959, 1989.
31. Birchall M, Henderson J, Studham J, et al. The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis. Clin Otolaryngol 20:204-210, 1995.
32. Small P, and Barrett D. Effects of high doses of topical steroids on both ragweed and histamine-induced nasal provocation. Ann Allergy 67:520-524, 1991.
33. Ciprandi G, Tosca M, Passalacqua G, and Canonica W. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge. Ann Allergy Asthma Immunol 86:433-438, 2001.
34. Penagos M, Compalati E, Tarantini F, et al. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 61:1280-1291, 2008.
35. Meltzer E, Berger W, Berkowitz R, et al. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. J Allergy Clin Immunol 104:107-114, 1999.